Protein expression profiling of primary mammary epithelial cells derived from MMTV-neu Mice Revealed that HER2/NEU-driven changes in protein expression are functionally clustered

IUBMB Life

Volumn 62, Issue 1, 2010, Pages 41-50

  Park, Sungwoo ^a   Lee, Kyung Min ^a   Ju, Ji Hyun ^a   Kim, Jaeyoon ^b   Noh, Dong Young ^c   Lee, Taehoon ^b   Shin, Incheol ^a  

^a Hanyang University   (South Korea)

^b Pohang University of Science and Technology (POSTECH)   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

Author keywords

HER2 NEU; Proteonomics; Signal transduction

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, MOUSE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST EPITHELIUM; CONTROLLED STUDY; DOWN REGULATION; FEMALE; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PURINE METABOLISM; UPREGULATION; ANIMAL; CELL ADHESION; CYTOLOGY; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENOTYPE; HUMAN; MAMMARY GLAND; MASS SPECTROMETRY; METABOLISM; PROTEIN MICROARRAY; PROTEOMICS; TRANSGENIC MOUSE; TUMOR CELL LINE; WESTERN BLOTTING;

MOUSE MAMMARY TUMOR VIRUS; MUS; MUS MUSCULUS;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL ADHESION; CELL LINE, TUMOR; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; GENOTYPE; HUMANS; MAMMARY GLANDS, HUMAN; MAMMARY TUMOR VIRUS, MOUSE; MASS SPECTROMETRY; MICE; MICE, TRANSGENIC; PROTEIN ARRAY ANALYSIS; PROTEOMICS; RECEPTOR, ERBB-2;

EID: 77950583500     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.276     Document Type: Article

References (55)

1. Schechter, A. L., Stern, D. F., Vaidyanathan, L., Decker, S. J., Drebin, J. A., Greene, M. I., and Weinberg, R. A. (1984) The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen. Nature 312, 513-516. (Pubitemid 15182278)
2. Yamamoto, T., Ikawa, S., Akiyama, T., Semba, K., Nomura, N., Miyajima, N., Saito, T., and Toyoshima, K. (1986) Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor. Nature 319, 230-234. (Pubitemid 16128786)
3. Ursini-Siegel, J., Schade, B., Cardiff, R. D., and Muller, W. J. (2007) Insights from transgenic mouse models of ERBB2-induced breast cancer. Nat. Rev. Cancer 7, 389-397
4. Olayioye, M. A., Neve, R. M., Lane, H. A., and Hynes, N. E. (2000) The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J. 19, 3159-3167.
5. Yarden, Y. and Sliwkowski, M. X. (2001) Untangling the ErbB signalling network. Nat. Rev. Mol. Cell. Biol. 2, 127-137.
6. Ross, J. S. and Fletcher, J. A. (1998) The HER-2/neu oncogene in breast cancer: prognostic facto, predictive facto, and target for therapy. Stem Cells 16, 413-428. (Pubitemid 28524507)
7. Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., and McGuire, W. L. (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235, 177-182.
8. Piccart-Gebhart, M. J. and Loi, S. M. (2005) Fulvestrant - ready to start its journey in the breast cancer adjuvant endocrine world? Eur. J. Cancer 41, 341-343.
9. Romond, E. H., Perez, E. A., Bryant, J., Suman, V. J., Geyer, C. E. Jr., Davidson, N. E., Tan-Chiu, E., Martino, S., Paik, S., Kaufman, P. A., Swain, S. M., Pisansky, T. M., Fehrenbacher, L., Kutteh, L. A., Vogel, V. G., Visscher, D. W., Yothers, G., Jenkins, R. B., Brown, A. M., Dakhil, S. R., Mamounas, E. P., Lingle, W. L., Klein, P. M., Ingle, J. N., and Wolmark, N. (2005) Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N. Engl. J. Med. 353, 1673-1684.
10. Bouchard, L., Lamarre, L., Tremblay, P. J., and Jolicoeur, P. (1989) Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene. Cell 57, 931-936. (Pubitemid 19168373)
11. Muller, W. J., Sinn, E., Pattengale, P. K., Wallace, R., and Leder, P. (1988) Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54, 105-115.
12. Guy, C. T., Webster, M. A., Schaller, M., Parsons, T. J., Cardiff, R. D., and Muller, W. J. (1992) Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc. Natl. Acad. Sci. USA 89, 10578-10582.
13. Lemoine, N. R., Staddon, S., Dickson, C., Barnes, D. M., and Gullick, W. J. (1990) Absence of activating transmembrane mutations in the cerbB-2 proto-oncogene in human breast cancer. Oncogene 5, 237-239. (Pubitemid 20095119)
14. Elias, J. E. and Gygi, S. P. (2007) Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat. Methods 4, 207-214.
15. Nakamura, T. and Oda, Y. (2007) Mass spectrometry-based quantitative proteomics. Biotechnol. Genet. Eng. Rev. 24, 147-163.
16. Frixen, U. H., Behrens, J., Sachs, M., Eberle, G., Voss, B., Warda, A., Lochner, D., and Birchmeier, W. (1991) E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J. Cell Biol. 113, 173-185. (Pubitemid 21909684)
17. Pujol, J. L., Grenier, J., Daures, J. P., Daver, A., Pujol, H., and Michel, F. B. (1993) Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer. Cancer Res. 53, 61-66. (Pubitemid 23019377)
18. Kasai, H., Allen, J. T., Mason, R. M., Kamimura, T., and Zhang, Z. (2005) TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT). Respir. Res. 6, 56. (Pubitemid 41410179)
19. Reed, J. C. (2003) Apoptosis-targeted therapies for cancer. Cancer Cell 3, 17-22.
20. Frisch, S. M. and Screaton, R. A. (2001) Anoikis mechanisms. Curr. Opin. Cell Biol. 13, 555-562.
21. Espana, L., Fernandez, Y., Rubio, N., Torregrosa, A., Blanco, J., and Sierra, A. (2004) Overexpression of Bcl-xL in human breast cancer cells enhances organ-selective lymph node metastasis. Breast Cancer Res. Treat. 87, 33-44.
22. Del Bufalo, D., Biroccio, A., Leonetti, C., and Zupi, G. (1997) Bcl-2 overexpression enhances the metastatic potential of a human breast cancer line. FASEB J. 11, 947-953. (Pubitemid 27425896)
23. Kumar, R., Mandal, M., Lipton, A., Harvey, H., and Thompson, C. B. (1996) Overexpression of HER2 modulates bcl-, bcl-X, and tamoxifen-induced apoptosis in human MCF-7 breast cancer cells. Clin. Cancer Res. 2, 1215-1219.
24. Hayden, M. S. and Ghosh, S. (2004) Signaling to NF-kappaB. Genes Dev. 18, 2195-2224.
25. Perkins, N. D. (2007) Integrating cell-signalling pathways with NF-kappaB and IKK function. Nature Rev. 8, 49-62.
26. Hatse, S., De Clercq, E., and Balzarini, J. (1999) Role of antimetabolites of purine and pyrimidine nucleotide metabolism in tumor cell differentiation. Biochem. pharmacol. 58, 539-555. (Pubitemid 29296875)
27. Spiegel, E. K., Colman, R. F., and Patterson, D. (2006) Adenylosuccinate lyase deficiency. Mol. Genet. Metab. 89, 19-31.
28. Wold, M. S. (1997) Replication protein A: a heterotrimeri, single-stranded DNA-binding protein required for eukaryotic DNA metabolism. Annu. Rev. Biochem. 66, 61-92.
29. Wang, Y., Putnam, C. D., Kane, M. F., Zhang, W., Edelmann, L., Russell, R., Carrion, D. V., Chin, L., Kucherlapati, R., Kolodner, R. D., and Edelmann, W. (2005) Mutation in Rpa1 results in defective DNA double-strand break repai, chromosomal instability and cancer in mice. Nat. Genet. 37, 750-755.
30. Woychik, N. A. and Hampsey, M. (2002) The RNA polymerase II machinery: structure illuminates function. Cell 108, 453-463. (Pubitemid 34260871)
31. Chen, B. S. and Hampsey, M. (2004) Functional interaction between TFIIB and the Rpb2 subunit of RNA polymerase II: implications for the mechanism of transcription initiation. Mol. Cell Biol. 24, 3983-3991.
32. Tsimberidou, A. M., Alvarado, Y., and Giles, F. J. (2002) Evolving role of ribonucleoside reductase inhibitors in hematologic malignancies. Expert Rev. Anticancer Ther. 2, 437-448.
33. Heidel, J. D., Liu, J. Y., Yen, Y., Zhou, B., Heale, B. S., Rossi, J. J., Bartlett, D. W., and Davis, M. E. (2007) Potent siRNA inhibitors of ribonucleotide reductase subunit RRM2 reduce cell proliferation in vitro and in vivo. Clin. Cancer Res. 13, 2207-2215.
34. Duxbury, M. S. and Whang, E. E. (2007) RRM2 induces NF-kappaB-dependent MMP-9 activation and enhances cellular invasiveness. Biochem. Biophys. Res. Commun. 354, 190-196.
35. Kohler, C., Gahm, A., Noma, T., Nakazawa, A., Orrenius, S., and Zhivotovsky, B. (1999) Release of adenylate kinase 2 from the mitochondrial intermembrane space during apoptosis. FEBS Lett. 447, 10-12. (Pubitemid 29134937)
36. Nobumoto, M., Yamada, M., Song, S., Inouye, S., and Nakazawa, A. (1998) Mechanism of mitochondrial import of adenylate kinase isozymes. J. Biochem. (Tokyo) 123, 128-135.
37. Lee, H. J., Pyo, J. O., Oh, Y., Kim, H. J., Hong, S. H., Jeon, Y. J., Kim, H., Cho, D. H., Woo, H. N., Song, S., Nam, J. H., Kim, H. J., Kim, K. S., and Jung, Y. K. (2007) AK2 activates a novel apoptotic pathway through formation of a complex with FADD and caspase-10. Nat. Cell Biol. 9, 1303-1310.
38. Nishino, T., Okamoto, K., Kawaguchi, Y., Hori, H., Matsumura, T., Eger, B. T., Pai, E. F., and Nishino, T. (2005) Mechanism of the conversion of xanthine dehydrogenase to xanthine oxidase: identification of the two cysteine disulfide bonds and crystal structure of a non-convertible rat liver xanthine dehydrogenase mutant. J. Biol. Chem. 280, 24888-24894.
39. Linder, N., Lundin, J., Isola, J., Lundin, M., Raivio, K. O., and Joensuu, H. (2005) Down-regulated xanthine oxidoreductase is a feature of aggressive breast cancer. Clin. Cancer Res. 11, 4372-4381.
40. Kurima, K., Warman, M. L., Krishnan, S., Domowicz, M., Krueger, R. C. Jr., Deyrup, A., and Schwartz, N. B. (1998) A member of a family of sulfate-activating enzymes causes murine brachymorphism. Proc. Natl. Acad. Sci. USA 95, 8681-8685.
41. ul Haque, M. F., King, L. M., Krakow, D., Cantor, R. M., Rusiniak, M. E., Swank, R. T., Superti-Furga, A., Haque, S., Abbas, H., Ahmad, W., Ahmad, M., and Cohn, D. H. (1998) Mutations in orthologous genes in human spondyloepimetaphyseal dysplasia and the brachymorphic mouse. Nat. Genet. 20, 157-162.
42. Ikeda, T., Mabuchi, A., Fukuda, A., Hiraoka, H., Kawakami, A., Yamamoto, S., Machida, H., Takatori, Y., Kawaguchi, H., Nakamura, K., and Ikegawa, S. (2001) Identification of sequence polymorphisms in two sulfation-related gene, PAPSS2 and SLC26A, and an association analysis with knee osteoarthritis. J. Hum. Genet. 46, 538-543.
43. Kobayashi, T., Sasaki, Y., Oshima, Y., Yamamoto, H., Mita, H., Suzuki, H., Toyota, M., Tokino, T., Itoh, F., Imai, K., and Shinomura, Y. (2006) Activation of the ribosomal protein L13 gene in human gastrointestinal cancer. Int. J. Mol. Med. 18, 161-170.
44. Bee, A., Ke, Y., Forootan, S., Lin, K., Beesley, C., Forrest, S. E., and Foster, C. S. (2006) Ribosomal protein l19 is a prognostic marker for human prostate cancer. Clin. Cancer Res. 12, 2061-2065.
45. Wang, H., Zhao, L. N., Li, K. Z., Ling, R., Li, X. J., and Wang, L. (2006) Overexpression of ribosomal protein L15 is associated with cell proliferation in gastric cancer. BMC Cancer 6, 91.
46. Zhu, Y., Lin, H., Li, Z., Wang, M., and Luo, J. (2001) Modulation of expression of ribosomal protein L7a (rpL7a) by ethanol in human breast cancer cells. Breast Cancer Res. Treat. 69, 29-38.
47. Henry, J. L., Coggin, D. L., and King, C. R. (1993) High-level expression of the ribosomal protein L19 in human breast tumors that overexpress erbB-2. Cancer Res. 53, 1403-1408.
48. Mani, A. and Gelmann, E. P. (2005) The ubiquitin-proteasome pathway and its role in cancer. J. Clin. Oncol. 23, 4776-4789.
49. Barnes, C. J., Li, F., Talukder, A. H., and Kumar, R. (2005) Growth factor regulation of a 26S proteasomal subunit in breast cancer. Clin. Cancer Res. 11, 2868-2874.
50. Pende, D., Bottino, C., Castriconi, R., Cantoni, C., Marcenaro, S., Rivera, P., Spaggiari, G. M., Dondero, A., Carnemolla, B., Reymond, N., Mingari, M. C., Lopez, M., Moretta, L., and Moretta, A. (2005) PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis. Molecular immunology 42, 463-469. (Pubitemid 39655955)
51. Edvardsen, K., Bock, E., Jirus, S., Frandsen, T. L., Holst-Hansen, C., Moser, C., Spang-Thomsen, M., Pedersen, N., Walsh, F. S., Vindelov, L. L., and Brunner, N. (1997) Effect of NCAM-transfection on growth and invasion of a human cancer cell line. APMIS 105, 919-930. (Pubitemid 28060192)
52. Zhang, D., Tai, L. K., Wong, L. L., Chiu, L. L., Sethi, S. K., and Koay, E. S. (2005) Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/neu-positive breast cancer. Mol. Cell Proteomics 4, 1686-1696. (Pubitemid 41749262)
53. Gharbi, S., Gaffney, P., Yang, A., Zvelebil, M. J., Cramer, R., Waterfield, M. D., and Timms, J. F. (2002) Evaluation of two-dimensional differential gel electrophoresis for proteomic expression analysis of a model breast cancer cell system. Mol. Cell Proteomics 1, 91-98.
54. Landis, M. D., Seachrist, D. D., Montanez-Wiscovich, M. E., Danielpour, D., and Keri, R. A. (2005) Gene expression profiling of cancer progression reveals intrinsic regulation of transforming growth factor-beta signaling in ErbB2/Neu-induced tumors from transgenic mice. Oncogene 24, 5173-5190. (Pubitemid 41192434)
55. Abd El-Rehim, D. M., Ball, G., Pinder, S. E., Rakha, E., Paish, C., Robertson, J. F., Macmillan, D., Blamey, R. W., and Ellis, I. O. (2005) High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses. Int. J. Cancer 116, 340-350. (Pubitemid 40993329)